NCT03433417已完成不适用
A Single-center, Prospective, Non-randomized, Open-label Clinical Study to Evaluate the Performance of the truSculpt Radiofrequency Device for Non-invasive Fat Reduction in Abdominal Tissue in Subjects Who Are Scheduled for Abdominoplasty
Cutera Inc.2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2017年6月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 12
- 试验地点
- 2
- 主要终点
- Number of Participants Who's Abdominal Tissue Showed Necrosis or Inflammatory Immune Cell Response
研究概览
简要总结
Clinical Study to Evaluate the Performance the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
详细描述
A single-center, prospective, non-randomized, open-label study to evaluate the truSculpt Radiofrequency Device for non-invasive fat reduction in abdominal tissue for up to 14 subjects. Measurement will be histological evaluation of tissue for selective fat necrosis, with sparing of the dermis and epidermis, following truSculpt treatment vs. untreated contralateral control.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 24 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male or Female, 24 to 60 years of age (inclusive)
- •Fitzpatrick Skin Type I - VI (Appendix 3)
- •Has visible fat bulges or skin laxity in the abdominal region
- •Scheduled to undergo surgery (abdominoplasty).
- •Non-smoking for at least 6 months and willing to refrain from smoking for the duration of the study.
- •Subject must agree to not undergo any other procedure(s) in the abdominal region during the study period.
- •Subject must be able to read, understand and sign the Informed Consent Form.
- •Subject must adhere to the follow-up schedule and study instructions.
- •Subject must adhere to the same diet/ exercise/medication regimen for the entire course of the study.
- •Willing to provide histology samples during the surgery from the intended to be harvested areas.
- •Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study, and no plans to become pregnant.
排除标准
- •Participation in a clinical trial of another device or drug in the target area during the study period.
- •Any type of prior cosmetic treatment to the target area within 12 months of study participation e.g., radiofrequency, cryolysis or light-based treatments.
- •Any prior invasive cosmetic surgery to the target area, such as liposuction.
- •Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve stimulator implant, cochlear implant or any other electronically, magnetically or mechanically activated implant.
- •Has metal implant(s) within the body, such as surgical clips, plates and screws, intrauterine device (IUD), artificial heart valves or artificial joints.
- •Significant concurrent illness, such as diabetes mellitus, cardiovascular disease, peripheral vascular disease or pertinent neurological disorders.
- •Diagnosed or documented immune system disorders.
- •History of any disease or condition that could impair wound healing.
- •History of diseases stimulated by heat, such as recurrent herpes zoster in the treatment area, unless treatment is conducted following a prophylactic regimen.
- •History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing in the treatment area.
- •Infection, dermatitis, rash or other skin abnormality in the target area.
- •Currently undergoing systemic chemotherapy or radiation treatment for cancer, or history of treatment in the target area within 3 months of study participation.
- •Pregnant or currently breastfeeding.
- •As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.
结局指标
主要结局
Number of Participants Who's Abdominal Tissue Showed Necrosis or Inflammatory Immune Cell Response
时间窗: 0 to 90 days
Descriptive histological evaluation of abdominal tissue for selective fat necrosis, with sparing of the dermis and epidermis, following one truSculpt treatment vs. untreated bilateral control. A responder is a biopsy sample that shows necrosis or inflammatory immune cell response.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Feasibility Study of the TruSculpt Radiofrequency DeviceTissue TighteningNCT03018587Cutera Inc.23
终止
不适用
Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body TumorsMetastatic Lesions in Vertebral BodiesNCT02081053DFINE Inc.30
Unknown
1 期
Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung CancerMultiple Primary Lung CancerNCT04840758The First Affiliated Hospital of Xiamen University39
已完成
不适用
The efficacy of pulsed radiofrequency for lumbosacral radicular pain a comparison of varying pulsed radiofrequency timeslumbosacral radicular painJPRN-UMIN000019836Kajiki Hospital60
招募中
不适用
A study on determining the safety of GYIDE in fibroid uterus specimeCTRI/2023/02/050132esa Medtech Pvt Ltd